MERCURY LABORATORIES
Back to Cashflow Statement
|
MERCURY LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹8.23 Cr | ₹2.45 Cr | ₹5.19 Cr | ₹8.21 Cr | ₹5.49 Cr |
What is the latest Cash Flow from Operating Activities ratio of MERCURY LABORATORIES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹8.23 Cr |
Mar2023 | ₹2.45 Cr |
Mar2022 | ₹5.19 Cr |
Mar2021 | ₹8.21 Cr |
Mar2020 | ₹5.49 Cr |
How is Cash Flow from Operating Activities of MERCURY LABORATORIES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹8.23 Cr | 235.44 | |
Mar2023 | ₹2.45 Cr | -52.75 | |
Mar2022 | ₹5.19 Cr | -36.83 | |
Mar2021 | ₹8.21 Cr | 49.54 | |
Mar2020 | ₹5.49 Cr | - |
Compare Cash Flow from Operating Activities of peers of MERCURY LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MERCURY LABORATORIES | ₹112.9 Cr | -1.3% | -2.3% | 19.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,914.0 Cr | -0.7% | -6.2% | 52.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,258.0 Cr | -3.1% | -5.5% | 66.2% | Stock Analytics | |
CIPLA | ₹121,563.0 Cr | -4.3% | -4.2% | 23% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,939.0 Cr | -3.2% | -5.9% | 16.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,960.7 Cr | -0.9% | -8.9% | 53.3% | Stock Analytics |
MERCURY LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MERCURY LABORATORIES | -1.3% |
-2.3% |
19.6% |
SENSEX | -3.3% |
-5.2% |
19.8% |
You may also like the below Video Courses